Novel Phenethylamines and Their Potential Interactions With Prescription Drugs: A Systematic Critical Review.
Therapeutic Drug Monitoring April 1, 2020 Funda Inan, Tibor M Brunt, Ramon R Contrucci et al. 9 citations
The novel phenethylamines 4-fluoroamphetamine (4-FA) and 2,5-dimethoxy-4-bromophenethylamine (2C-B) fall in the top 10 most used new psychoactive substances (NPSs) among high-risk substance users. Various phenethylamines and NPS are also highly used in populations with mental disorders, depression, or attention deficit hyperactivity disorder (ADHD). Moreover, NPS use is highly prevalent among...